Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, healt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dent J (Basel)
Main Authors: Thomas, Christian, Bartsch, Georg, Walter, Christian, Borgmann, Hendrik, Brandt, Maximilian Peter, Höfner, Thomas, Haferkamp, Axel, Tsaur, Igor
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5806937/
https://ncbi.nlm.nih.gov/pubmed/29563470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/dj4030028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados